Morgan Stanley Institutional Vitality Portfolio (MSVMX)
| Fund Assets | 2.00M |
| Expense Ratio | 2.05% |
| Min. Investment | $1,000 |
| Turnover | 27.00% |
| Dividend (ttm) | 0.10 |
| Dividend Yield | 1.50% |
| Dividend Growth | n/a |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Jun 9, 2026 |
| Previous Close | 6.36 |
| YTD Return | -0.34% |
| 1-Year Return | 23.18% |
| 5-Year Return | n/a |
| 52-Week Low | 5.05 |
| 52-Week High | 6.72 |
| Beta (5Y) | n/a |
| Holdings | 33 |
| Inception Date | Dec 31, 2021 |
About MSVMX
Morgan Stanley Institutional Fund, Inc. Vitality Portfolio Class C is a mutual fund focused on long-term capital appreciation through investment in the U.S. healthcare sector. The fund primarily targets companies engaged in the discovery, development, production, or distribution of products and services driven by advances in healthcare. Its portfolio is actively managed, with an emphasis on firms that demonstrate sustainable competitive advantages, robust research and development pipelines, financial strength, and favorable risk/reward profiles. The fund includes holdings in leading industry players such as pharmaceuticals, biotechnology, medical devices, and healthcare services. This approach offers exposure to one of the most dynamic and innovative segments of the U.S. equity market. The fund’s investment philosophy seeks to capitalize on growth trends within healthcare, supporting its role as a specialized option for investors aiming to participate in the ongoing evolution of medical technologies and services.
Performance
MSVMX had a total return of 23.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.67%.
Top 10 Holdings
49.09% of assets| Name | Symbol | Weight |
|---|---|---|
| argenx SE | ARGX | 8.03% |
| Eli Lilly and Company | LLY | 7.79% |
| Ascendis Pharma A/S | ASND | 5.48% |
| Nektar Therapeutics | NKTR | 4.75% |
| Thermo Fisher Scientific Inc. | TMO | 4.28% |
| Align Technology, Inc. | ALGN | 4.18% |
| Enliven Therapeutics, Inc. | ELVN | 3.90% |
| 10x Genomics, Inc. | TXG | 3.77% |
| NewAmsterdam Pharma Company N.V. | NAMS | 3.57% |
| Structure Therapeutics Inc. | GPCR | 3.36% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 9, 2026 | $0.05761 | Jun 9, 2026 |
| Dec 11, 2025 | $0.0379 | Dec 11, 2025 |